Repeatable Evaluation of Functional Intra-procedural Signals for Effect in Pulsed Field Ablation REFINE-PFA

Part of paid clinical trials in Ypsilanti, Michigan.

Sponsor
CathVision ApS
Study ID
NCT07275151
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
21 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Pulmonary vein isolation ablation — DEVICE
    Electrical isolation of the pulmonary veins to treat atrial fibrillation

Study Details

The study is a prospective, exploratory observational study with the ECGenius® System and the PFAnalyzer software module in PFA cases using the FaraPulse PFA system. The cohort will be patients with paroxysmal or persistent atrial fibrillation (AF) who undergo PVI using this system.

Key Dates

First listed
Dec 10, 2025
Start date
Jul 22, 2026
Status verified
Jul 2026
Primary completion
Oct 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
40 participants (estimated)

Primary Outcome Measure

Pulmonary vein isolation [ Time Frame: intra-procedural ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Trinity Health Ann Arbor HospitalYpsilantiMichigan48197
Xu Gao, MD
[email protected]
734-712-7787
Xu Gao, MD (PRINCIPAL_INVESTIGATOR)
The Valley HospitalParamusNew Jersey07652
Dan Musat, MD
[email protected]
201-432-7837
Jessica Mailim, RN
Dan Musat, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Ypsilanti, MI

By condition
Atrial fibrillation
By specialty
CardiologyHeart disease
By research site
Trinity Health Ann Arbor Hospital· Ypsilanti, MIThe Valley Hospital· Paramus, NJ

Related Studies